LGALS3 and liver dysplastic nodule: These results suggest that patients who developed DN had higher circulating Gal-3 levels compared to those who did not develop DN (SMD: 1.03; 95% CI: 0.52 to 1.54, I2 = 94.4%) (Fig. 4).